2.11th Yahya Cohen Memorial Lecture: An in vivo comparative study of the ability of derived mesenchymal stem cells in the treatment of partial growth arrest.
James H P HUI ; Li LI ; Hong-Wei OUYANG ; Yee-Hong TEO ; Eng-Hin LEE
Annals of the Academy of Medicine, Singapore 2009;38(1):84-87
Few in vivo studies had previously been attempted in reaffirming the in vitro data in current literature. This study evaluated the ability of mesenchymal stem cells (MSCs) isolated from bone marrow, periosteum and fat to treat partial growth arrest in immature New Zealand white (NZW) rabbits. A physeal arrest model in an immature rabbit was created. The bony bridge was excised 3 weeks later, and MSCs from various sources were transferred into the physeal defect of different rabbits. Group I consisted of bone marrow-derived MSCs, Group II: periosteumderived MSCs, Group III: fat-derived MSCs. Contra-lateral tibiae, without undergoing operation, served as self-control. The animals were subsequently sacrificed, with radiological and histological analyses performed. All MSCs demonstrated chondrogenic and osteogenic differentiation potentials in vitro. In correction of varus angulation groups I and II exhibited superior results when compared to group III (P <0.05). The length discrepancies between operated and normal tibiae in groups I, II and III were significantly corrected when compared to the control group (P <0.01). In conclusion, bone marrow and periosteum derived stem cells provided better correction of physeal arrest in rabbits. The source of MSCs itself could influence the success in the treatment of growth arrest.
Animals
;
Bone Diseases
;
therapy
;
Bone Regeneration
;
Cell Culture Techniques
;
methods
;
Disease Models, Animal
;
Growth Disorders
;
therapy
;
Mesenchymal Stem Cell Transplantation
;
methods
;
Mesenchymal Stromal Cells
;
cytology
;
Osteogenesis
;
Rabbits
;
Tibia
;
growth & development
;
injuries
3.Association between the elderly frequent attender to the emergency department and 30-day mortality: A retrospective study over 10 years
Yuzeng SHEN ; Tay Chien YEE ; Edward Wee Kwan TEO ; Nan LIU ; Lam Wei SHAO ; Marcus Eng Hock ONG
World Journal of Emergency Medicine 2018;9(1):20-25
BACKGROUND:To determine if elderly frequent attenders are associated with increased 30-day mortality, assess resource utilization by the elderly frequent attenders and identify associated characteristics that contribute to mortality. METHODS:Retrospective observational study of electronic clinical records of all emergency department (ED) visits over a 10-year period to an urban tertiary general hospital in Singapore. Patients aged 65 years and older, with 3 or more visits within a calendar year were identified. Outcomes measured include 30-day mortality, admission rate, admission diagnosis and duration spent at ED. Chi-square-tests were used to assess categorical factors and Student t-test was used to assess continuous variables on their association with being a frequent attender. Univariate and multivariate logistic regressions were conducted on all significant independent factors on to the outcome variable (30-day mortality), to determine factor independent odds ratios of being a frequent attender. RESULTS:1.381 million attendance records were analyzed. Elderly patients accounted for 25.5% of all attendances, of which 31.3% are frequent attenders. Their 30-day mortality rate increased from 4.0% in the first visit, to 8.8% in the third visit, peaking at 10.2% in the sixth visit. Factors associated with mortality include patients with neoplasms, ambulance utilization, male gender and having attended the ED the previous year. CONCLUSION:Elderly attenders have a higher 30-day mortality risk compared to the overall ED population, with mortality risk more marked for frequent attenders. This study illustrates the importance and need for interventions to address frequent ED visits by the elderly, especially in an aging society.
4.A practical clinical approach to liver fibrosis.
Rahul KUMAR ; Eng Kiong TEO ; Choon How HOW ; Teck Yee WONG ; Tiing Leong ANG
Singapore medical journal 2018;59(12):628-633
Liver fibrosis is a slow, insidious process involving accumulation of extracellular matrix protein in the liver. The stage of liver fibrosis in chronic liver disease (CLD) determines overall morbidity and mortality; the higher the stage, the worse the prognosis. Noninvasive composite scores can be used to determine whether patients with CLD have significant or advanced fibrosis. Patients with low composite scores can be safely followed up in primary care with periodic reassessment. Those with higher scores should be referred to a specialist. As the epidemic of diabetes mellitus, obesity and non-alcoholic fatty liver diseases is rising, CLD is becoming more prevalent. Easy-to-use fibrosis assessment composite scores can identify patients with minimal or advanced fibrosis, and should be an integral part of decision-making. Patients with cirrhosis, high composite scores, chronic hepatitis B with elevated alanine aminotransferase and aspartate aminotransferase, or deranged liver panel of uncertain aetiology should be referred to a specialist.
Alanine Transaminase
;
blood
;
Aspartate Aminotransferases
;
blood
;
Decision Making
;
End Stage Liver Disease
;
complications
;
diagnosis
;
therapy
;
Hepatitis B
;
complications
;
Humans
;
Liver
;
pathology
;
Liver Cirrhosis
;
complications
;
diagnosis
;
therapy
;
Non-alcoholic Fatty Liver Disease
;
complications
;
diagnosis
;
therapy
;
Prognosis
;
Referral and Consultation
;
Treatment Outcome